Cite
Lee SH, Yoon JH, Min GJ, et al. Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study. Int J Hematol. 2021;115(1):135-139doi: 10.1007/s12185-021-03231-6.
Lee, S. H., Yoon, J. H., Min, G. J., Park, S. S., Park, S., Lee, S. E., Cho, B. S., Eom, K. S., Kim, Y. J., Kim, H. J., Min, C. K., Cho, S. G., Lee, J. W., & Lee, S. (2022). Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study. International journal of hematology, 115(1), 135-139. https://doi.org/10.1007/s12185-021-03231-6
Lee, Seung-Hwan, et al. "Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study." International journal of hematology vol. 115,1 (2022): 135-139. doi: https://doi.org/10.1007/s12185-021-03231-6
Lee SH, Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Lee JW, Lee S. Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study. Int J Hematol. 2022 Jan;115(1):135-139. doi: 10.1007/s12185-021-03231-6. Epub 2021 Oct 06. PMID: 34617186.
Copy
Download .nbib